Physician profile
Daniel J Gallagher
NPI 1437186178
$2,281.00
in general payments reported to CMS, 2019-2025
24 companies · $40.91 in 2025
The $40.91 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $88.79 · 2021: $188 · 2022: $310 · 2023: $597 · 2024: $805 · 2025: $40.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,442.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $317.66 | 2023-2024 | A/R Femoral Nail, Actify, Proven Gen-Flex Ps Knee System |
| Stryker Corporation | $249.80 | 2019-2025 | Axsos, Tornier Perform Reversed Glenoid |
| Depuy Synthes Sales INC. | $239.66 | 2019-2024 | Tfn-Advance, Monovisc |
| Sanara Medtech INC. | $200.34 | 2024 | Celleraterx |
| Medacta USA, INC. | $176.07 | 2022-2024 | Gmk Sphere |
| Zimmer Biomet Holdings, INC. | $171.37 | 2021-2023 | |
| Heron Therapeutics, INC. | $148.18 | 2023 | Zynrelef |
| Davol INC. | $116.31 | 2022 | |
| Orthalign INC | $101.00 | 2023 | Orthalign Plus |
| Pacira Therapeutics, INC. | $76.23 | 2019-2021 | |
| Smith+Nephew, INC. | $65.52 | 2021 | |
| Fidia Pharma USA INC. | $59.71 | 2021-2022 | |
| Organogenesis INC. | $59.47 | 2023-2024 | Puraply |
| Boston Scientific Corporation | $48.03 | 2019 | |
| Vericel Corporation | $44.39 | 2024 | Maci |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $32.50 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $30.49 | 2022 | |
| Endo Pharmaceuticals INC. | $27.00 | 2020-2021 | |
| Bioventus LLC | $24.72 | 2020 | |
| Ethicon US, LLC | $23.11 | 2019 | |
| Medtronic, INC. | $21.45 | 2022 | |
| Amgen INC. | $17.44 | 2020 | |
| Sanofi-Aventis U.S. LLC | $15.41 | 2020 | |
| Esaote North America, INC. | $15.14 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Gallagher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.